Blue Star Helium has completed Stage 1 of its Galactica development, tying six wells into the Pinon Canyon facility and starting spot-priced helium sales. The company raised A$10 million to fund further project expansion and working capital.
- Stage 1 of Galactica development completed with six wells tied in
- Pinon Canyon Plant begins integrated helium production and spot sales
- Targeting CO2 liquefaction sales in June 2026 quarter
- A$10 million institutional placement oversubscribed and progressing
- Plans underway for 24/7 operations and broader acreage expansion
Integrated Helium Production Kicks Off at Pinon Canyon
Blue Star Helium (ASX:BNL) has turned a corner with its Pinon Canyon Plant in Colorado now operating in integrated mode. The amine unit, designed to strip CO2 from raw gas, has been successfully commissioned, enabling refined helium to be loaded into tube trailers for spot-market sales. This milestone follows the completion of Stage 1 of the Galactica development programme, with six wells; including Jackson 2, Jackson 4, and State 9; tied into the facility and ready for production.
The company is gearing up to transition to continuous 24/7 operations once automation, safety, and remote monitoring systems are fully commissioned. CEO Trent Spry visited the site in March, engaging with joint venture partner Helium One Global and hosting investors, who responded positively to the asset’s quality and strategic positioning in the US helium market.
Capital Raising Fuels Next Phase of Growth
Backing the operational progress, Blue Star completed an oversubscribed A$10 million institutional placement at A$0.006 per share in late March, with A$6 million settled and the remaining A$4 million pending shareholder approval at the upcoming AGM. This capital injection, combined with proceeds from a prior entitlement offer and option exercises, is earmarked for advancing the Galactica and Pegasus projects as well as general working capital.
The placement’s strong reception from domestic and international investors underscores confidence in Blue Star’s growth trajectory and market opportunity. The company’s recent funding success builds on earlier capital raises, including a non-renounceable entitlement offer that raised over A$1 million in January 2026. This financial foundation supports the company’s plans to ramp up helium production and expand its footprint.
CO2 Monetisation and Broader Expansion Plans
Looking ahead, Blue Star targets the June 2026 quarter for commencing CO2 liquefaction and trailer loading, contingent on offtake agreements. The tie-in of the high-CO2 Jackson 27 well is scheduled to coincide with this phase, potentially unlocking a significant new revenue stream from CO2 sales. Beyond Galactica-Pegasus, the company has identified up to 20 additional locations at its Serenity prospect for future CO2 development.
Stage 2 of the Galactica-Pegasus expansion contemplates 20 to 30 new drilling locations, with a focus on optimising production scalability and resource recovery. The joint venture partners are also evaluating the potential for new processing facilities across the acreage, subject to regulatory approvals and market conditions.
Commercial Strategy Amid Global Supply Disruptions
The global helium market remains volatile, with supply chain disruptions and rationing driving demand for reliable, domestically sourced US helium. Blue Star’s offtake strategy balances near-term spot sales with ongoing negotiations for long-term contracts with US counterparties. This dual approach aims to underpin sustained revenue as production scales, reflecting the company’s response to structural market shifts.
Blue Star’s operational ramp-up and commercial progress follow a series of milestones including the commissioning of the CO2 removal unit at Pinon Canyon and the first commercial helium production in late 2025. The company’s ability to convert spot sales into longer-term agreements will be critical to its revenue stability going forward.
With the Pinon Canyon Plant now filling helium tube trailers under spot-market arrangements, Blue Star is poised to capitalise on tightening helium supplies and growing demand in high-tech industries. The company’s recent developments align with its strategic roadmap to expand helium and CO2 production across its Colorado acreage, leveraging operational learnings and market momentum.
Bottom Line?
Blue Star’s transition to integrated helium production and successful capital raise set the stage for scaling operations, but the timing and scale of CO2 sales and expansion drilling remain key variables to watch.
Questions in the middle?
- How quickly will Blue Star convert spot helium sales into long-term offtake agreements?
- What regulatory or market hurdles could impact the planned Stage 2 drilling and new processing facilities?
- How will CO2 liquefaction sales shape overall project economics and investor returns?